Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sajeeda S, Lalit Kumar & Ruchi Verma. (2022) Lamotrigine—A Review of Analytical Methods Developed for Pharmaceutical Formulations and Biological Matrices. Critical Reviews in Analytical Chemistry 52:7, pages 1451-1460.
Read now
Read now
Giulia Liparoti, Beatrice Burchiani, Elisabetta Mencaroni, Domenico Tripodi, Giuseppe Di Cara & Alberto Verrotti. (2022) Individualizing doses of antiepileptic drugs. Expert Opinion on Drug Metabolism & Toxicology 18:3, pages 219-233.
Read now
Read now
Hussein Algahtani, Bader Shirah, Samah Almatrafi, Mohammad H. Al-Qahtani, Angham Abdulrahman Abdulkareem & Muhammad Imran Naseer. (2021) A Novel Variant in CWF19L1 Gene in a Family with Late-Onset Autosomal Recessive Cerebellar Ataxia 17. Neurological Research 43:2, pages 141-147.
Read now
Read now
Alessandra Morano, Luigi Iannone, Caterina Palleria, Martina Fanella, Anna Teresa Giallonardo, Giovambattista De Sarro, Emilio Russo & Carlo Di Bonaventura. (2019) Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy. Expert Opinion on Pharmacotherapy 20:1, pages 25-39.
Read now
Read now
Articles from other publishers (33)
Raman Sankar, Michael Chez, J. Eric Pina-Garza, Tracy Dixon-Salazar, J. Robert Flamini, Ann Hyslop, Patricia McGoldrick, John J. Millichap, Trevor Resnick, Jong M. Rho & Steven Wolf. (2023) Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion. Seizure: European Journal of Epilepsy 110, pages 42-57.
Crossref
Crossref
Lanyan Fang, Zhichuan Li, Minori Kinjo, Sara Lomonaco, Nan Zheng, Wenlei Jiang & Liang Zhao. (2022) Generic lamotrigine extended‐release tablets are bioequivalent to innovator drug in fully replicated crossover bioequivalence study. Epilepsia 64:1, pages 152-161.
Crossref
Crossref
Nevin Tham & Sarah R. Langley. (2022) Evaluating the robustness of connectivity methods to noise for in silico drug repurposing studies. Frontiers in Systems Biology 2.
Crossref
Crossref
Bhavatharini PA, Shri Sanghavi G, Grace Thomas & Arun KP. (2022) Dosage Optimization of Lamotrigine in Pregnancy: A Pharmacometric Approach Using Modeling and Simulation. The Journal of Clinical Pharmacology 62:12, pages 1557-1565.
Crossref
Crossref
Qinghong Hou, Lulu Wang, Feng Xiao, Le Wang, Xiaoyan Liu, Lina Zhu, Yi Lu, Wenfu Zheng & Xingyu Jiang. (2022) Dual targeting nanoparticles for epilepsy therapy. Chemical Science 13:43, pages 12913-12920.
Crossref
Crossref
Jiaquan Li, Yangjia Huang, Qi An, Wenyu Li, Jianting Li, Hongji Liu, Dezhi Yang, Yang Lu & Zhengzheng Zhou. (2022) Discovered two polymorphs and two solvates of lamotrigine-tolfenamic acid salt: Thermal behavior and crystal morphological differences. International Journal of Pharmaceutics 628, pages 122310.
Crossref
Crossref
Xianjing Zhou, Linwei Zeng, Yi Wang, Cenglin Xu, Zhong Chen & Sunliang Cui. (2022) Discovery of triazenyl triazoles as Nav1.1 channel blockers for treatment of epilepsy. Bioorganic & Medicinal Chemistry Letters 75, pages 128946.
Crossref
Crossref
N. M. Zhuravlev, N. A. Shnayder, E. E. Vaiman, A. K. Abdyrakhmanova, M. M. Petrova, E. N. Bochanova, I. V. Romanova, O. A. Gavrilyuk, N. V. Lareva & R. F. Nasyrova. (2022) Interindividual Variability of Anticonvulsant-Induced QT Prolongation Risk. Personalized Psychiatry and Neurology 2:1, pages 22-45.
Crossref
Crossref
Maja Hochbaum, Ricardo Kienitz, Felix Rosenow, Juliane Schulz, Lena Habermehl, Lisa Langenbruch, Stjepana Kovac, Susanne Knake, Felix von Podewils, Sophie von Brauchitsch, Mario Hamacher, Adam Strzelczyk & Laurent M. Willems. (2022) Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020. Epilepsy & Behavior 130, pages 108666.
Crossref
Crossref
Aynaz Zarghampour, Milad Moradi, Elaheh Rahimpour, Fleming Martinez, Hongkun Zhao & Abolghasem Jouyban. (2021) Solubility study of lamotrigine in the aqueous mixture of choline chloride based deep eutectic solvent at different temperatures. Journal of Molecular Liquids 344, pages 117935.
Crossref
Crossref
Shokufeh Bagheri, Rasool Haddadi, Sahar Saki, Masoumeh Kourosh‐Arami & Alireza Komaki. (2021) The effect of sodium channels on neurological/neuronal disorders: A systematic review. International Journal of Developmental Neuroscience 81:8, pages 669-685.
Crossref
Crossref
Alexis S. McLaine, Page E. Yaxley, Anda A. Young & Edward S. Cooper. (2021) Successful management of massive lamotrigine extended‐release intoxication in a dog. Clinical Case Reports 9:12.
Crossref
Crossref
Marta Karaźniewicz-Łada, Anna K. Główka, Aniceta A. Mikulska & Franciszek K. Główka. (2021) Pharmacokinetic Drug–Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients. International Journal of Molecular Sciences 22:17, pages 9582.
Crossref
Crossref
N. A. Shnayder, M. M. Petrova, K. V. Petrov & R. F. Nasyrova. (2021) Pharmacological predictors of heart rate and conductivity disorders in juvenile myoclonic epilepsy. Epilepsy and paroxysmal conditions 13:2, pages 168-179.
Crossref
Crossref
Shruthi Shankar RamanVedha Hari B NarayananRamyadevi Durai. (2021) Lamotrigine Nanoparticle Laden Polymer Composite Oral Dissolving Films for Improving Therapeutic Potential of the Hydrophobic Antiepileptic Molecule. ASSAY and Drug Development Technologies 19:1, pages 2-16.
Crossref
Crossref
Karina Sommerfeld-Klatta, Barbara Zielińska-Psuja, Marta Karaźniewcz-Łada & Franciszek K. Główka. (2020) New Methods Used in Pharmacokinetics and Therapeutic Monitoring of the First and Newer Generations of Antiepileptic Drugs (AEDs). Molecules 25:21, pages 5083.
Crossref
Crossref
Cinthya Eloisa Chávez-Castillo, Susanna Edith Medellín-Garibay, Rosa del Carmen Milán-Segovia, Ildefonso Rodríguez-Leyva & Silvia Romano-Moreno. (2020) Dosing Recommendations Based on Population Pharmacokinetics of Lamotrigine in Mexican Adult Patients With Epilepsy. Journal of Pharmaceutical Sciences 109:9, pages 2902-2908.
Crossref
Crossref
Laurent M. Willems, Sebastian Bauer, Kolja Jahnke, Martin Voss, Felix Rosenow & Adam Strzelczyk. (2020) Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review. CNS Drugs 34:8, pages 801-826.
Crossref
Crossref
José Eduardo Juárez-Hernández, Michel Gutiérrez-Ceniceros, José Rodrigo González-Ramírez, Mara Medeiros, Bruce Carleton, Colin Ross & Gilberto Castañeda-Hernández. (2020) Pharmacokinetic-Pharmacogenomic Model for Chinese Children treated with Lamotrigine also Applies for Mexican Children. Therapeutic Drug Monitoring Publish Ahead of Print.
Crossref
Crossref
Peter S. Talbot. 2020. Seminars in Clinical Psychopharmacology. Seminars in Clinical Psychopharmacology
362
391
.
Zhao Zhang, Xia Zhou, Jinping Liu, Lu Qin, Lu Yu, Xiaomin Pang, Wei Ye & Jinou Zheng. (2020) Longitudinal assessment of resting-state fMRI in temporal lobe epilepsy: A two-year follow-up study. Epilepsy & Behavior 103, pages 106858.
Crossref
Crossref
Amitava Dasgupta & Matthew D. Krasowski. 2020. Therapeutic Drug Monitoring Data. Therapeutic Drug Monitoring Data
99
158
.
Fenglai Xiao, Matthias J. Koepp & Dong Zhou. (2019) Pharmaco-fMRI: A Tool to Predict the Response to Antiepileptic Drugs in Epilepsy. Frontiers in Neurology 10.
Crossref
Crossref
Ye Ding, Xiaoping Tan, Shuo Zhang & Yang Guo. (2019) Pharmacokinetic changes and therapeutic drug monitoring of lamotrigine during pregnancy. Brain and Behavior 9:7.
Crossref
Crossref
Xiaonian Han, Jing Huang, Jianhua Lv, Li Ma, Lirong Peng, Jinping Wang, Xiaojing Nie, Li Xia & Xin Zan. (2019) The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy. PLOS ONE 14:1, pages e0210600.
Crossref
Crossref
Alessandro Galgani, Caterina Palleria, Luigi Francesco Iannone, Giovambattista De Sarro, Filippo Sean Giorgi, Marta Maschio & Emilio Russo. (2018) Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs. Frontiers in Neurology 9.
Crossref
Crossref
Sandra Ventura, Márcio Rodrigues, Amílcar Falcão & Gilberto Alves. (2018) Evaluation of the effects of Citrus aurantium (bitter orange) extract on lamotrigine pharmacokinetics: Insights from in vivo studies in rats. Food and Chemical Toxicology 121, pages 166-172.
Crossref
Crossref
Tianbo Li & Jun Chen. 2018. Ion Channels in Health and Sickness. Ion Channels in Health and Sickness.
Marta Vázquez, Cecilia Maldonado, Natalia Guevara, Andrea Rey, Pietro Fagiolino, Antonella Carozzi & Carlos Azambuja. (2018) Lamotrigine-Valproic Acid Interaction Leading to Stevens–Johnson Syndrome. Case Reports in Medicine 2018, pages 1-5.
Crossref
Crossref
Mortaza Iranifam, Nasim Rahmati Hendekhale & Haider A. J. Al Lawati. (2018)
The Co
3
O
4
nanoparticle-enhanced luminol-O
2
chemiluminescence reaction used for the determination of nortriptyline hydrochloride and lamotrigine in pharmaceutical and environmental samples
. Analytical Methods 10:4, pages 429-438.
Crossref
Crossref
Kuldeep Kumar Namdev, Jaya Dwivedi, Deepak Chandra Chilkoti & Swapnil Sharma. (2018) A simple, rapid and stability indicating validated method for quantification of lamotrigine in human plasma and dry plasma spot using LC-ESI–MS/MS: Application in clinical study. Journal of Chromatography B 1072, pages 362-369.
Crossref
Crossref
Chung-Ying Lin, Xavier C.C. Fung, Mehdi Nikoobakht, Andrea Burri & Amir H. Pakpour. (2017) Using the Theory of Planned Behavior incorporated with perceived barriers to explore sexual counseling services delivered by healthcare professionals in individuals suffering from epilepsy. Epilepsy & Behavior 74, pages 124-129.
Crossref
Crossref
Rocco Salvatore Calabrò. (2017) Lamotrigine-induced persistent genital arousal disorder: An unusual side effect. Epilepsy & Behavior 68, pages 234-235.
Crossref
Crossref